Artificial intelligence for assessment of vascular involvement and tumor resectability on CT in patients with pancreatic cancer

Artificial intelligence for assessment of vascular involvement and tumor resectability on CT in patients with pancreatic cancer

Abstract Objective This study aimed to develop and evaluate an automatic model using artificial intelligence (AI) for quantifying vascular involvement and classifying tumor resectability stage in patients with pancreatic ductal adenocarcinoma (PDAC), primarily to support radiologists in referral cen...

Full description

Bibliographic Details
Main Authors:	Jacqueline I. Bereska, Boris V. Janssen, C. Yung Nio, Marnix P. M. Kop, Geert Kazemier, Olivier R. Busch, Femke Struik, Henk A. Marquering, Jaap Stoker, Marc G. Besselink, Inez M. Verpalen, for the Pancreatobiliary and Hepatic Artificial Intelligence Research (PHAIR) consortium
Format:	Article
Language:	English
Published:	SpringerOpen 2024-02-01
Series:	European Radiology Experimental
Subjects:	Artificial intelligence Carcinoma (pancreatic ductal) Pancreatic neoplasms Tomography (x-ray computed) Unsupervised machine learning
Online Access:	https://doi.org/10.1186/s41747-023-00419-9

Similar Items

Pathomorphological characteristics of the restructuring of pancreatic ductal system in chronic pancreatitis
by: Kovalenko I.S.
Published: (2013-01-01)

Pancreatic ductal adenocarcinoma arising from the pancreatic parenchyma compressed by a huge pancreatic lipoma: a case report
by: Seiji Nakahara, et al.
Published: (2023-08-01)

Recent Developments in the Treatment of Pancreatic Cancer
by: Jorge Paulino, et al.
Published: (2023-10-01)

Association of Neutrophil, Platelet, and Lymphocyte Ratios with the Prognosis in Unresectable and Metastatic Pancreatic Cancer
by: Jessica Allen, et al.
Published: (2020-10-01)

Pancreatic tail cancer in the setting of pancreatitis with a review of the literature: A case report
by: Shinji Rho, et al.
Published: (2023-10-01)

Differentiating benign from malignant pancreatic cysts on computed tomography
by: Rajesh Kumar Yadav, et al.
Published: (2020-01-01)

Utility of Contrast-Enhanced Computed Tomography for Differentiating Pancreatic Ductal Adenocarcinoma from Inflammatory Mass in Chronic Calcific Pancreatitis
by: Thara Pratap, et al.
Published: (2024-01-01)

Metabolic profiling of induced acute pancreatitis and pancreatic cancer progression in a mutant Kras mouse model
by: Tatiana J. Carneiro, et al.
Published: (2022-08-01)

Management of Metastatic Pancreatic Cancer—Comparison of Global Guidelines over the Last 5 Years
by: Monika Pajewska, et al.
Published: (2023-09-01)

Protective or Risk Factors for Postoperative Pancreatic Fistulas in Malignant Pathology
by: Alin Mihai Vasilescu, et al.
Published: (2021-11-01)

Cachexia index as a prognostic predictor after resection of pancreatic ductal adenocarcinoma
by: Tomonari Shimagaki, et al.
Published: (2023-11-01)

Correlations of miR-1290 and miR-191-5p with laboratory parameters as a useful test to differentiate pancreatic cancer from chronic pancreatitis: preliminary study
by: Małgorzata Guz, et al.
Published: (2023-06-01)

SWIP—a stabilized window for intravital imaging of the murine pancreas
by: Wei Du, et al.
Published: (2022-06-01)

Undifferentiated carcinoma of the pancreas with osteoclast-like giant cells reported in an asymptomatic patient: a rare case and literature review
by: Ramen Sakhi, et al.
Published: (2017-12-01)

A feasible CT feature to differentiate focal‐type autoimmune pancreatitis from pancreatic ductal adenocarcinoma
by: Chaobin He, et al.
Published: (2019-10-01)

Disparities in Pancreatic Ductal Adenocarcinoma—The Significance of Hispanic Ethnicity, Subgroup Analysis, and Treatment Facility on Clinical Outcomes
by: Andrea N. Riner, et al.
Published: (2020-06-01)

The TGF-β superfamily as potential therapeutic targets in pancreatic cancer
by: Rachel R. Tindall, et al.
Published: (2024-03-01)

The Latest Advancement in Pancreatic Ductal Adenocarcinoma Therapy: A Review Article for the Latest Guidelines and Novel Therapies
by: Marwa Elsayed, et al.
Published: (2021-04-01)

Alpha Smooth Muscle Actin (αSMA) Immunohistochemistry Use in the Differentiation of Pancreatic Cancer from Chronic Pancreatitis
by: Katarzyna Winter, et al.
Published: (2021-12-01)

Pancreatic Neoplasms: CT Evaluation of the Uncommon Presentations of Common Lesions and Common Presentations of the Uncommon Lesions!
by: Sneha Satish Deshpande, et al.
Published: (2022-12-01)

An Autopsy Case of Anaplastic Pancreatic Ductal Carcinoma (Spindle Cell Type) Multiple Onset in the Pancreas
by: Hiroyuki Ito, et al.
Published: (2019-04-01)

Radiomics and Its Applications and Progress in Pancreatitis: A Current State of the Art Review
by: Gaowu Yan, et al.
Published: (2022-06-01)

Clinical features and images of malignant lymphoma localized in the pancreatic head to differentiate from pancreatic ductal adenocarcinoma: a case series study
by: Naohiro Kato, et al.
Published: (2023-05-01)

The Prospect of Harnessing the Microbiome to Improve Immunotherapeutic Response in Pancreatic Cancer
by: Sherise Rogers, et al.
Published: (2023-12-01)

The Disproportionate Rise in Pancreatic Cancer in Younger Women Is Due to a Rise in Adenocarcinoma and Not Neuroendocrine Tumors: A Nationwide Time-Trend Analysis Using 2001–2018 United States Cancer Statistics Databases
by: Yi Jiang, et al.
Published: (2024-02-01)

Recurrence Patterns for Pancreatic Ductal Adenocarcinoma after Upfront Resection Versus Resection Following Neoadjuvant Therapy: A Comprehensive Meta-Analysis
by: Bathiya Ratnayake, et al.
Published: (2020-07-01)

Modifiable Pancreatic Ductal Adenocarcinoma (PDAC) Risk Factors
by: Natalia Michalak, et al.
Published: (2023-06-01)

Clinically impactful metabolic subtypes of pancreatic ductal adenocarcinoma (PDAC)
by: Jannat Pervin, et al.
Published: (2023-10-01)

Clinical Features and Prognostic Impact of Pancreatic Ductal Adenocarcinoma without Dilatation of the Main Pancreatic Duct: A Single-Center Retrospective Analysis
by: Takuya Takayanagi, et al.
Published: (2023-03-01)

Retroperitoneal lymphangioma as the final diagnosis of a middle-aged woman with abdominal pain: a case report
by: Hamid Asadzadeh Aghdaei, et al.
Published: (2023-03-01)

Does acute pancreatitis herald pancreatic ductal adenocarcinoma? A multicenter electronic health research network study
by: Ritu R. Singh, et al.
Published: (2023-02-01)

Cancer stem cells and mesenchymal stem cells in pancreatic ductal adenocarcinoma
by: V. O. Tumanskyi, et al.
Published: (2019-06-01)

Modified gemcitabine plus nab‐paclitaxel regimen in advanced pancreatic ductal adenocarcinoma
by: Jane E. Rogers, et al.
Published: (2020-08-01)

Soluble Compounds Released by Hypoxic Stroma Confer Invasive Properties to Pancreatic Ductal Adenocarcinoma
by: Dajia Liu, et al.
Published: (2020-10-01)

Diffuse pancreatic parenchymal atrophy, an imaging finding predictive of the development of pancreatic ductal adenocarcinoma: A case–control study
by: Akinobu Koiwai, et al.
Published: (2023-06-01)

Acinar-to-Ductal Metaplasia (ADM): On the Road to Pancreatic Intraepithelial Neoplasia (PanIN) and Pancreatic Cancer
by: Louis Marstrand-Daucé, et al.
Published: (2023-06-01)

Therapeutic Status and Available Strategies in Pancreatic Ductal Adenocarcinoma
by: Gitika Thakur, et al.
Published: (2021-02-01)

Current Screening Strategies for Pancreatic Cancer
by: Petr Vanek, et al.
Published: (2022-08-01)

Cetuximab, gemcitabine and radiotherapy in locally advanced pancreatic cancer: Long-term results of the randomized controlled phase II PARC trial
by: Jakob Liermann, et al.
Published: (2022-05-01)

Limited Role of the Apparent Diffusion Coefficient (ADC) for Tumor Grade and Overall Survival in Resectable Pancreatic Ductal Adenocarcinoma
by: Deniece M. Riviere, et al.
Published: (2024-03-01)